Q-012

N/A

Report date: 2025/01/26 16:16:56
NME

Base Information

Drug NameQ-012
Drug Alias NameQ-012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase modulators
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniquest Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniquest Pty Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A